-
1
-
-
31444447411
-
Strategies for the prevention and treatment of osteoporosis during early postmenopause
-
DOI 10.1016/j.ajog.2005.08.049, PII S0002937805013724
-
MF Delaney 2006 Strategies for the prevention and treatment of osteoporosis during early postmenopause Am J Obstet Gynecol 194 S12 S23 16448872 10.1016/j.ajog.2005.08.049 (Pubitemid 43152483)
-
(2006)
American Journal of Obstetrics and Gynecology
, vol.194
, Issue.2 SUPPL.
-
-
Delaney, M.F.1
-
2
-
-
0036068423
-
Biochemical indices of bone turnover and the assessment of fracture probability
-
DOI 10.1007/s001980200068
-
O Johnell A Oden C De Laet P Garnero PD Delmas JA Kanis 2002 Biochemical indices of bone turnover and the assessment of fracture probability Osteoporos Int 13 523 526 12111011 10.1007/s001980200068 1:STN:280:DC%2BD38zmslSntA%3D%3D (Pubitemid 34790623)
-
(2002)
Osteoporosis International
, vol.13
, Issue.7
, pp. 523-526
-
-
Johnell, O.1
Oden, A.2
De Laet, C.3
Garnero, P.4
Delmas, P.D.5
Kanis, J.A.6
-
3
-
-
54849410645
-
Using biochemical markers of bone turnover in clinical practice
-
18939390 10.3949/ccjm.75.10.739
-
FR Singer DR Eyre 2008 Using biochemical markers of bone turnover in clinical practice Cleve Clin J Med 75 739 750 18939390 10.3949/ccjm.75.10.739
-
(2008)
Cleve Clin J Med
, vol.75
, pp. 739-750
-
-
Singer, F.R.1
Eyre, D.R.2
-
4
-
-
0034526072
-
The use of biochemical markets of bone turnover in osteoporosis
-
DOI 10.1007/s001980070002
-
PD Delmas R Eastell P Garnero MJ Seibel J Stepan 2000 The use of biochemical markers of bone turnover in osteoporosis. Committee of scientific advisors of the international osteoporosis foundation Osteoporos Int 11 S2 S17 11193237 10.1007/s001980070002 (Pubitemid 32039509)
-
(2000)
Osteoporosis International
, vol.11
, Issue.SUPPL. 6
-
-
Delmas, P.D.1
Eastell, R.2
Garnero, P.3
Seibel, M.J.4
Stepan, J.5
-
5
-
-
23444452077
-
One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis
-
DOI 10.1056/NEJMoa050336
-
DM Black JP Bilezikian KE Ensrud SL Greenspan L Palermo T Hue TF Lang JA McGowan CJ Rosen 2005 One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis N Engl J Med 353 555 565 16093464 10.1056/NEJMoa050336 1:CAS:528:DC%2BD2MXnsVWmtb0%3D (Pubitemid 41138937)
-
(2005)
New England Journal of Medicine
, vol.353
, Issue.6
, pp. 555-565
-
-
Black, D.M.1
Bilezikian, J.P.2
Ensrud, K.E.3
Greenspan, S.L.4
Palermo, L.5
Hue, T.6
Lang, T.F.7
McGowan, J.A.8
Rosen, C.J.9
-
6
-
-
33947504500
-
Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis. A randomized trial
-
SL Greenspan HG Bone MP Ettinger DA Hanley R Lindsay JR Zanchetta CM Blosch AL Mathisen SA Morris TB Marriott 2007 Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial Ann Intern Med 146 326 339 17339618 (Pubitemid 351650593)
-
(2007)
Annals of Internal Medicine
, vol.146
, Issue.5
, pp. 326-339
-
-
Greenspan, S.L.1
Bone, H.G.2
Ettinger, M.P.3
Hanley, D.A.4
Lindsay, R.5
Zanchetta, J.R.6
Blosch, C.M.7
Mathisen, A.L.8
Morris, S.A.9
Marriott, T.B.10
-
7
-
-
57449090596
-
Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84
-
18983947 10.1016/j.bone.2008.09.019 1:CAS:528:DC%2BD1cXhsFahtLjJ
-
RR Recker SP Bare SY Smith A Varela MA Miller SA Morris J Fox 2009 Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84 Bone 44 113 119 18983947 10.1016/j.bone.2008.09.019 1:CAS:528:DC%2BD1cXhsFahtLjJ
-
(2009)
Bone
, vol.44
, pp. 113-119
-
-
Recker, R.R.1
Bare, S.P.2
Smith, S.Y.3
Varela, A.4
Miller, M.A.5
Morris, S.A.6
Fox, J.7
-
8
-
-
0141684971
-
The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis
-
DOI 10.1056/NEJMoa031975
-
DM Black SL Greenspan KE Ensrud L Palermo JA McGowan TF Lang P Garnero ML Bouxsein JP Bilezikian CJ Rosen 2003 The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis N Engl J Med 349 1207 1215 14500804 10.1056/NEJMoa031975 1:CAS:528:DC%2BD3sXns1Kmsrw%3D (Pubitemid 37152030)
-
(2003)
New England Journal of Medicine
, vol.349
, Issue.13
, pp. 1207-1215
-
-
Black, D.M.1
Greenspan, S.L.2
Ensrud, K.E.3
Palermo, L.4
McGowan, J.A.5
Lang, T.F.6
Garnero, P.7
Bouxsein, M.L.8
Bilezikian, J.P.9
Rosen, C.J.10
-
9
-
-
0035837553
-
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis
-
DOI 10.1056/NEJM200105103441904
-
RM Neer CD Arnaud JR Zanchetta R Prince GA Gaich JY Reginster AB Hodsman EF Eriksen S Ish-Shalom HK Genant O Wang BH Mitlak 2001 Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis N Engl J Med 344 1434 1441 11346808 10.1056/ NEJM200105103441904 1:CAS:528:DC%2BD3MXktVSgsbw%3D (Pubitemid 32402100)
-
(2001)
New England Journal of Medicine
, vol.344
, Issue.19
, pp. 1434-1441
-
-
Neer, R.M.1
Arnaud, C.D.2
Zanchetta, J.R.3
Prince, R.4
Gaich, G.A.5
Reginster, J.-Y.6
Hodsman, A.B.7
Eriksen, E.F.8
Ish-Shalom, S.9
Genant, H.K.10
Wang, O.11
Mitlak, B.H.12
Mellstrom, D.13
Oefjord, E.S.14
Marcinowska-Suchowierska, E.15
Salmi, J.16
Mulder, H.17
Halse, J.18
Sawicki, A.Z.19
-
10
-
-
19044364417
-
Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis
-
DOI 10.1359/JBMR.050105
-
P Chen JH Satterwhite AA Licata EM Lewiecki AA Sipos DM Misurski RB Wagman 2005 Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis J Bone Miner Res 20 962 970 15883636 10.1359/JBMR.050105 1:CAS:528:DC%2BD2MXlsFehtr0%3D (Pubitemid 40712820)
-
(2005)
Journal of Bone and Mineral Research
, vol.20
, Issue.6
, pp. 962-970
-
-
Chen, P.1
Satterwhite, J.H.2
Licata, A.A.3
Lewiecki, E.M.4
Sipos, A.A.5
Misurski, D.M.6
Wagman, R.B.7
-
11
-
-
9144233479
-
The Effects of Strontium Ranelate on the Risk of Vertebral Fracture in Women with Postmenopausal Osteoporosis
-
DOI 10.1056/NEJMoa022436
-
PJ Meunier C Roux E Seeman S Ortolani JE Badurski TD Spector J Cannata A Balogh EM Lemmel S Pors-Nielsen R Rizzoli HK Genant JY Reginster 2004 The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis N Engl J Med 350 459 468 14749454 10.1056/NEJMoa022436 1:CAS:528:DC%2BD2cXos1Snsw%3D%3D (Pubitemid 38133766)
-
(2004)
New England Journal of Medicine
, vol.350
, Issue.5
, pp. 459-468
-
-
Meunier, P.J.1
Roux, C.2
Seeman, E.3
Ortolani, S.4
Badurski, J.E.5
Spector, T.D.6
Cannata, J.7
Balogh, A.8
Lemmel, E.-M.9
Pors-Nielsen, S.10
Rizzoli, R.11
Genant, H.K.12
Reginster, J.-Y.13
-
12
-
-
20044361853
-
Strontium ranelate: A novel mode of action optimizing bone formation and resorption
-
DOI 10.1007/s00198-004-1753-8
-
PJ Marie 2005 Strontium ranelate: a novel mode of action optimizing bone formation and resorption Osteoporos Int 16 S7 S10 15578159 10.1007/s00198-004- 1753-8 1:CAS:528:DC%2BD2MXisVSltrc%3D (Pubitemid 40768190)
-
(2005)
Osteoporosis International
, vol.16
, Issue.SUPPL. 1
-
-
Marie, P.J.1
-
13
-
-
0023714259
-
Effect of strontium chloride on bone resorption induced by prostaglandin E2 in cultured bone
-
3196163 10.1007/BF00570150 1:CAS:528:DyaL1MXisVyj
-
A Matsumoto 1988 Effect of strontium chloride on bone resorption induced by prostaglandin E2 in cultured bone Arch Toxicol 62 240 241 3196163 10.1007/BF00570150 1:CAS:528:DyaL1MXisVyj
-
(1988)
Arch Toxicol
, vol.62
, pp. 240-241
-
-
Matsumoto, A.1
-
14
-
-
0030176233
-
The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro
-
DOI 10.1016/8756-3282(96)00080-4
-
E Canalis M Hott P Deloffre Y Tsouderos PJ Marie 1996 The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro Bone 18 517 523 8805991 10.1016/8756-3282(96)00080-4 1:CAS:528: DyaK28Xkslagu7k%3D (Pubitemid 26257871)
-
(1996)
Bone
, vol.18
, Issue.6
, pp. 517-523
-
-
Canalis, E.1
Hott, M.2
Deloffre, P.3
Tsouderos, Y.4
Marie, P.J.5
-
15
-
-
0034902167
-
Strontium ranelate inhibits bone resorption while maintaining bone formation in alveolar bone in monkeys (Macaca fascicularis)
-
DOI 10.1016/S8756-3282(01)00484-7, PII S8756328201004847
-
J Buehler P Chappuis JL Saffar Y Tsouderos A Vignery 2001 Strontium ranelate inhibits bone resorption while maintaining bone formation in alveolar bone in monkeys (Macaca fascicularis) Bone 29 176 179 11502480 10.1016/S8756-3282(01)00484-7 1:CAS:528:DC%2BD3MXlvFWkurg%3D (Pubitemid 32734498)
-
(2001)
Bone
, vol.29
, Issue.2
, pp. 176-179
-
-
Buehler, J.1
Chappuis, P.2
Saffar, J.L.3
Tsouderos, Y.4
Vignery, A.5
-
16
-
-
0027316220
-
An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats
-
PJ Marie M Hott D Modrowski PC De J Guillemain P Deloffre Y Tsouderos 1993 An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats J Bone Miner Res 8 607 615 8511988 10.1002/jbmr.5650080512 1:CAS:528: DyaK2cXksFSjsbs%3D (Pubitemid 23127921)
-
(1993)
Journal of Bone and Mineral Research
, vol.8
, Issue.5
, pp. 607-615
-
-
Marie, P.J.1
Hott, M.2
Modrowski, D.3
De Pollak, C.4
Guillemain, J.5
Deloffre, P.6
Tsouderos, Y.7
-
17
-
-
44849121708
-
Combination anabolic and antiresorptive therapy for osteoporosis: Opening the anabolic window
-
18430397 10.1007/s11914-008-0005-9
-
JP Bilezikian 2008 Combination anabolic and antiresorptive therapy for osteoporosis: opening the anabolic window Curr Osteoporos Rep 6 24 30 18430397 10.1007/s11914-008-0005-9
-
(2008)
Curr Osteoporos Rep
, vol.6
, pp. 24-30
-
-
Bilezikian, J.P.1
-
18
-
-
68949100644
-
Comparative effects of teriparatide and strontium ranelate on bone biopsies and biochemical markers of bone turnover in postmenopausal women with osteoporosis
-
19338452 10.1359/jbmr.090315 1:CAS:528:DC%2BD1MXhtFaitrvF
-
RR Recker F Marin S Ish-Shalom R Moricke F Hawkins G Kapetanos MP de la Pena J Kekow J Farrerons B Sanz H Oertel J Stepan 2009 Comparative effects of teriparatide and strontium ranelate on bone biopsies and biochemical markers of bone turnover in postmenopausal women with osteoporosis J Bone Miner Res 24 1358 1368 19338452 10.1359/jbmr.090315 1:CAS:528:DC%2BD1MXhtFaitrvF
-
(2009)
J Bone Miner Res
, vol.24
, pp. 1358-1368
-
-
Recker, R.R.1
Marin, F.2
Ish-Shalom, S.3
Moricke, R.4
Hawkins, F.5
Kapetanos, G.6
De La Pena, M.P.7
Kekow, J.8
Farrerons, J.9
Sanz, B.10
Oertel, H.11
Stepan, J.12
-
19
-
-
21044447888
-
Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study
-
DOI 10.1210/jc.2004-1774
-
JY Reginster E Seeman MC De Vernejoul S Adami J Compston C Phenekos JP Devogelaer MD Curiel A Sawicki S Goemaere OH Sorensen D Felsenberg PJ Meunier 2005 Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: treatment of peripheral osteoporosis (TROPOS) study J Clin Endocrinol Metab 90 2816 2822 15728210 10.1210/jc.2004-1774 1:CAS:528:DC%2BD2MXkt1Wgt78%3D (Pubitemid 40686329)
-
(2005)
Journal of Clinical Endocrinology and Metabolism
, vol.90
, Issue.5
, pp. 2816-2822
-
-
Reginster, J.Y.1
Seeman, E.2
De Vernejoul, M.C.3
Adami, S.4
Compston, J.5
Phenekos, C.6
Devogelaer, J.P.7
Curiel, M.D.8
Sawicki, A.9
Goemaere, S.10
Sorensen, O.H.11
Felsenberg, D.12
Meunier, P.J.13
-
20
-
-
79952694264
-
Comparing and contrasting the effects of strontium ranelate and other osteoporosis drugs on microarchitecture
-
20464378 10.1007/s00198-010-1250-1 1:CAS:528:DC%2BC3cXmtVSnsb4%3D
-
S Ferrari 2010 Comparing and contrasting the effects of strontium ranelate and other osteoporosis drugs on microarchitecture Osteoporos Int 21 S437 S442 20464378 10.1007/s00198-010-1250-1 1:CAS:528:DC%2BC3cXmtVSnsb4%3D
-
(2010)
Osteoporos Int
, vol.21
-
-
Ferrari, S.1
-
21
-
-
68949100645
-
Commentary: Could strontium ranelate have a synergistic role in the treatment of osteoporosis?
-
19558313 10.1359/jbmr.090601 1:CAS:528:DC%2BD1MXhtFaitrvE
-
GM Blake JE Compston I Fogelman 2009 Commentary: could strontium ranelate have a synergistic role in the treatment of osteoporosis? J Bone Miner Res 24 1354 1357 19558313 10.1359/jbmr.090601 1:CAS:528:DC%2BD1MXhtFaitrvE
-
(2009)
J Bone Miner Res
, vol.24
, pp. 1354-1357
-
-
Blake, G.M.1
Compston, J.E.2
Fogelman, I.3
-
22
-
-
37649018995
-
Interpreting change scores for pain and functional status in low back pain: Towards international consensus regarding minimal important change
-
18165753 10.1097/BRS.0b013e31815e3a10
-
RW Ostelo RA Deyo P Stratford G Waddell P Croft KM Von LM Bouter HC de Vet 2008 Interpreting change scores for pain and functional status in low back pain: towards international consensus regarding minimal important change Spine Phila Pa 1976 33 90 94 18165753 10.1097/BRS.0b013e31815e3a10
-
(2008)
Spine Phila Pa 1976
, vol.33
, pp. 90-94
-
-
Ostelo, R.W.1
Deyo, R.A.2
Stratford, P.3
Waddell, G.4
Croft, P.5
Von, K.M.6
Bouter, L.M.7
De Vet, H.C.8
-
23
-
-
18844414587
-
Potential use of biochemical markers of bone turnoverfor assessing the effect of calcium supplementation and predicting fracture risk
-
DOI 10.1016/j.dinthera.2005.03.003, PII S0149291805000469
-
SM Weisman V Matkovic 2005 Potential use of biochemical markers of bone turnover for assessing the effect of calcium supplementation and predicting future fracture risk Clin Ther 27 299 308 15878383 10.1016/j.dinthera.2005.03. 003 1:CAS:528:DC%2BD2MXjvVygs7o%3D (Pubitemid 40692748)
-
(2005)
Clinical Therapeutics
, vol.27
, Issue.3
, pp. 299-308
-
-
Weisman, S.M.1
Matkovic, V.2
-
24
-
-
77950273246
-
CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials
-
20332511 10.1136/bmj.c869
-
D Moher S Hopewell KF Schulz V Montori PC Gotzsche PJ Devereaux D Elbourne M Egger DG Altman 2010 CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials BMJ 340 c869 20332511 10.1136/bmj.c869
-
(2010)
BMJ
, vol.340
, pp. 869
-
-
Moher, D.1
Hopewell, S.2
Schulz, K.F.3
Montori, V.4
Gotzsche, P.C.5
Devereaux, P.J.6
Elbourne, D.7
Egger, M.8
Altman, D.G.9
-
25
-
-
77952274419
-
CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials
-
20334633 10.1186/1741-7015-8-18
-
KF Schulz DG Altman D Moher 2010 CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials BMC Med 8 18 20334633 10.1186/1741-7015-8-18
-
(2010)
BMC Med
, vol.8
, pp. 18
-
-
Schulz, K.F.1
Altman, D.G.2
Moher, D.3
|